The present disclosure is generally directed to neuroactive 17(20)-Z-vinylcyano-substituted compound of Formula (I) and (II), as referenced herein, and pharmaceutically acceptable salts thereof, for use as, for example, an anesthetic, and/or in the treatment of disorders relating to GABA function and activity. The present disclosure is further directed to pharmaceutical compositions comprising such compounds.
本公开涉及一般指向化合物的神经活性17(20)-Z-
乙烯基氰基取代物,其
化学式为(I)和(II),并且其药学上可接受的盐,例如用作
麻醉剂,和/或用于治疗与
GABA功能和活性相关的疾病。本公开还涉及包含这种化合物的药物组合物。